Greytown Advisors Inc. Royalty Pharma PLC Transaction History

Greytown Advisors Inc.

$169 Million
Q2 2024

A detailed history of Greytown Advisors Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Greytown Advisors Inc. holds 72,196 shares of RPRX stock, worth $2.04 Million. This represents 1.12% of its overall portfolio holdings.

Number of Shares

72,196

Previous 71,978 0.3%

Holding current value

$2.04 Million

Previous $2.19 Million 12.91%

% of portfolio

1.12%

Previous 1.24%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$26.26 - $29.9 $5,724 - $6,518	218 Added 0.3%	72,196 $1.9 Million
Q1 2024 May 15, 2024	SELL	$27.46 - $31.33 $77,217 - $88,099	-2,812 Reduced 3.76%	71,978 $2.19 Million
Q4 2023 Feb 14, 2024	BUY	$26.21 - $29.22 $4,953 - $5,522	189 Added 0.25%	74,790 $2.1 Million
Q3 2023 Nov 06, 2023	BUY	$26.26 - $31.38 $142,066 - $169,765	5,410 Added 7.82%	74,601 $2.02 Million
Q2 2023 Aug 11, 2023	BUY	$29.6 - $36.56 $17,552 - $21,680	593 Added 0.86%	69,191 $2.13 Million
Q1 2023 May 15, 2023	BUY	$32.77 - $39.4 $456,060 - $548,329	13,917 Added 25.45%	68,598 $2.47 Million
Q4 2022 Feb 13, 2023	BUY	$39.17 - $44.04 $164,827 - $185,320	4,208 Added 8.34%	54,681 $2.16 Million
Q3 2022 Nov 14, 2022	SELL	$39.88 - $44.65 $3.31 Million - $3.71 Million	-83,036 Reduced 62.2%	50,473 $2.03 Million
Q2 2022 Aug 15, 2022	BUY	$37.53 - $44.22 $88,795 - $104,624	2,366 Added 1.8%	133,509 $5.61 Million
Q1 2022 May 16, 2022	BUY	$37.46 - $42.44 $159,579 - $180,794	4,260 Added 3.36%	131,143 $5.11 Million
Q4 2021 Feb 14, 2022	BUY	$35.17 - $42.48 $723,165 - $873,473	20,562 Added 19.34%	126,883 $5.06 Million
Q3 2021 Nov 15, 2021	BUY	$36.14 - $42.24 $3.84 Million - $4.49 Million	106,321 New	106,321 $3.84 Million

Others Institutions Holding RPRX

# of Institutions

398

Shares Held

291M

Call Options Held

305K

Put Options Held

138K

View Full List

About Royalty Pharma plc

Ticker RPRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 437,139,008
Market Cap $12.3B
Description
Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...

More about RPRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Greytown Advisors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Greytown Advisors Inc. with notifications on news.

Account

Greytown Advisors Inc. Royalty Pharma PLC Transaction History